Home
HelpTest Code CSTCE Cystatin C with Estimated Glomerular Filtration Rate (eGFR), Serum
Specimen Required
Collection Container/Tube:
Preferred: Serum gel
Acceptable: Red top
Submission Container/Tube: Plastic vial
Specimen Volume: 0.5 mL
Collection Instructions:
1. Serum gel tubes should be centrifuged within 2 hours of collection.
2. Red-top tubes should be centrifuged and serum aliquoted into a plastic vial within 2 hours of collection.
Useful For
Assessing kidney function in patients suspected of having kidney disease
Monitoring treatment response in patients with kidney disease
An index of glomerular filtration rate (GFR), especially in patients where serum creatinine may be misleading (eg, very obese, older adults, or malnourished patients)
Calculation of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) cystatin C estimated GFR for patients where serum creatinine may be misleading (eg, very obese, older adults, or malnourished patients)
Method Name
Immunoturbidimetric
Reporting Name
Cystatin C with Estimated GFR, SSpecimen Type
SerumSpecimen Minimum Volume
0.25 mL
Specimen Stability Information
| Specimen Type | Temperature | Time | Special Container |
|---|---|---|---|
| Serum | Refrigerated (preferred) | 14 days | |
| Frozen | 30 days | ||
| Ambient | 7 days |
Reference Values
CYSTATIN C:
18-49 years: 0.63-1.03 mg/L
≥50 years: 0.67-1.21 mg/L
0-17 years: Reference values have not been established. Refer to estimated glomerular filtration rate (eGFR).
ESTIMATED GFR:
>60 mL/min/BSA (body surface area)
Adult eGFR: Estimated GFR calculated using CKD-EPI Cystatin C equation.(1)
Pediatric eGFR: Estimated GFR calculated using Schwartz Cystatin C equation.(12)
Interpretation
Cystatin C:
Cystatin C inversely correlates with the glomerular filtration rate (GFR), that is, elevated levels of cystatin C indicate decreased GFR. Cystatin C may provide more accurate assessment of GFR for very obese, older adults, or malnourished patients than creatinine. Cystatin C equation does not require patient ethnic data and can be used for those patients with this information unavailable.
Due to immaturity of kidney function, cystatin C levels are higher in neonates less than 3 months of age.(3)
Estimated GFR:
Chronic kidney disease (CKD) is defined as the presence of persistent and usually progressive reduction in GFR (GFR <60 mL/min/1.73 m[2]) and/or albuminuria (>30 mg of urinary albumin per gram of urinary creatinine), regardless of GFR.
According to the National Kidney Foundation Kidney Disease Outcome Quality Initiative (KDOQI) classification, among patients with CKD, irrespective of diagnosis, the stage of disease should be assigned based on the level of kidney function.(4)
Table. Kidney Disease: Improving Global Outcomes (KDIGO) guidelines provide the following GFR categories
|
Stage |
Description |
GFR mL/min/BSA |
|
1 |
Kidney damage with normal or increased GFR |
90 |
|
2 |
Kidney damage with mild decrease in GFR |
60-89 |
|
3A |
Mild to moderate decrease in GFR |
45-59 |
|
3B |
Moderate to severe decrease in GFR |
30-44 |
|
4 |
Severe decrease in GFR |
15-29 |
|
5 |
Kidney failure |
<15 (or dialysis) |
Clinical Reference
1. Inker LA, Schmid CH, Tighiouart H, et al; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012 Jul;367(1):20-29. doi: 10.1056/NEJMoa1114248
2. Frazee E, Rule AD, Lieske JC, et al: Cystatin C-guided vancomycin dosing in critically ill patients: a quality improvement project. Am J Kidney Dis. 2017 May;69(5):658-666. doi: 10.1053/j.ajkd.2016.11.016
3. Buehrig CK, Larson TS, Bergert JH, et al: Cystatin C is superior to serum creatinine for the assessment of renal function. J Am Soc Nephrol. 2001;12:194A
4. Inker LA, Astor BC, Fox CH, et al: KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis. 2014 May;63(5):713-735. doi: 10.1053/j.ajkd.2014.01.416
5. Grubb AO: Cystatin C--properties and use as a diagnostic marker. Adv Clin Chem. 2000;35:63-99. doi: 10.1016/s0065-2423(01)35015-1
6. Coll E, Botey A, Alvarez L, et al: Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis. 2000 Jul;36(1):29-34. doi: 10.1053/ajkd.2000.8237
7. Larsson A, Hansson LO, Flodin M, Katz R, Shlipak MG: Calibration of the Siemens cystatin C immunoassay has changed over time. Clin Chem. 2011 May;57(5):777-778. doi: 10.1373/clinchem.2010.159848
8. Voskoboev NV, Larson TS, Rule AD, Lieske JC: Importance of cystatin C assay standardization. Clin Chem. 2011 Aug;57(8):1209-1211. doi: 10.1373/clinchem.2011.164798
9. Nitsch D, Sandling JK, Byberg L et al: Fetal, developmental, and parental influences on cystatin C in childhood: the Uppsala Family Study. Am J Kidney Dis. 2011 Jun;57(6):863-872. doi: 10.1053/j.ajkd.2010.12.025
10. Voskoboev NV, Larson TS, Rule AD, Lieske JC: Analytic and clinical validation of a standardized cystatin C particle enhanced turbidimetric assay (PETIA) to estimate glomerular filtration rate. Clin Chem Lab Med. 2012 Mar;50(9):1591-1596. doi: 10.1515/cclm-2012-0063
11. Finney H, Newman DJ, Thakkar H, Fell JM, Price CP: Reference ranges for the plasma cystatin C and creatinine measurements in premature infants, neonates, and older children. Arch Dis Child. 2000 Jan;82(1):71-75. doi: 10.1136/adc.82.1.71
12. Schwartz GJ, Schneider MF, Maier PS, et al: Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int. 2012 Aug;82(4):445-453. doi: 10.1038/ki.2012.169
Day(s) Performed
Report Available
Same day/1 to 3 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82610
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| CSTCE | Cystatin C with Estimated GFR, S | 87430-5 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| GFRC | eGFR by Cystatin C | 50210-4 |
| CSTNC | Cystatin C, S | 33863-2 |
Forms
If not ordering electronically, complete, print, and send one of the following forms with the specimen:
-General Test Request (T239)
-Cardiovascular Test Request Form (T724)
-Renal Diagnostics Test Request (T830)